Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 14,261 shares at $16.66 ($238K) on 2026-02-09, disclosed to the SEC on 2026-02-09.
Scheduled sale ($238k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |